William Blair analyst Ryan Daniels has maintained their bullish stance on TMDX stock, giving a Buy rating today.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ryan Daniels’s rating is based on a combination of factors that indicate a positive outlook for TransMedics Group. The company has experienced a rebound in its flight data at the start of the fourth quarter, suggesting a recovery from the seasonal decline observed in the third quarter. This recovery is evidenced by an increase in the average number of daily flights, which has risen to 25.7 in October, surpassing the third quarter’s average of 22.8 flights per day.
Furthermore, the upward trend in flight volumes throughout October is a promising sign for the company’s operational performance. The consistent increase in weekly flight volumes suggests a strengthening demand for TransMedics’ services, which is a positive indicator for future growth. These factors contribute to Ryan Daniels’s confidence in the company’s potential, leading to a Buy rating for TransMedics Group’s stock.
In another report released today, Needham also upgraded the stock to a Buy with a $148.00 price target.
Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is neutral on the stock.